According to new clinical trial data published in The Clinical Journal of Pain, the daily and long-term use of cannabis improves analgesia and reduces opioid use in patients who suffer from treatment-resistant chronic pain. At the Hebrew University in Israel, researchers looked at a group of 176 chronic pain patients who had been unresponsive to conventional pharmaceutical medications. The subjects inhaled up to 20 grams of THC-dominant cannabis strains for a minimum of six months.
As a result of the study, the majority of participants, about 66%, experienced improved pain symptom scores after the use of cannabis therapy, and most participants reported improved quality of life. Overall, the subjects' consumption of opioid drugs declined by 44% by the end of the trial, along with a significant percentage of participants who discontinued their opioid therapy completely throughout the course of the study. Authors wrote, "In summary, this long-term prospective cohort suggests that cannabis treatment in a mixed group of patients with treatment-resistant chronic pain may result in improved pain, sleep and quality of life outcomes, as well as reduced opioid use."
This information has been provided by the Daily Chronic and approved by our Chief Medical Officer.